MicroRNA as New Tools for Prostate Cancer Risk Assessment and Therapeutic Intervention: Results from Clinical Data Set and Patients’ Samples

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">References</td><td align="center">miRs associated with stemness properties</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Liu et al. (2012) [<a href="/journals/bmri/2014/146170/#B125">125</a>]</td><td align="center">miR-34a</td></tr><tr><td align="left">Saini et al. (2012) [<a href="/journals/bmri/2014/146170/#B126">126</a>]</td><td align="center">miR-708</td></tr><tr><td align="left">Huang et al. (2012) [<a href="/journals/bmri/2014/146170/#B127">127</a>]</td><td align="center">miR-143 and miR-145</td></tr><tr><td align="left">Hsieh et al. (2013) [<a href="/journals/bmri/2014/146170/#B129">129</a>]</td><td align="center">miR-320</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

MicroRNAs associated with stemness properties acquisition.

BioMed Research International

tab5

Table 5

Table 5: MicroRNA as New Tools for Prostate Cancer Risk Assessment and Therapeutic Intervention: Results from Clinical Data Set and Patients’ Samples 

Table 5 | MicroRNA as New Tools for Prostate Cancer Risk Assessment and Therapeutic Intervention: Results from Clinical Data Set and Patients’ Samples 